Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
01/2001
01/03/2001EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments
01/03/2001EP1064262A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments
01/03/2001EP1064256A1 Bicyclo [2.2.1] heptanes and related compounds
01/03/2001EP1064021A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment
01/03/2001EP1063996A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v 1a? and v 2? receptors
01/03/2001EP1063982A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
01/03/2001CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors
01/03/2001CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
01/03/2001CN1060173C Heterocyclic compound with activity against diabetes and preparation nad application of same
01/02/2001US6169107 Indoloylguanidine derivatives
01/02/2001US6169106 Indolinones having kinase inhibitory activity
01/02/2001US6168776 Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
01/02/2001CA2174034C Novel tricyclic amides, processes for their preparation and the pharmaceutical compositions which contain them
01/02/2001CA2016880C Herbicidal 3-(3,4,5,6-tetrahydrophthalimido)-cinnamic esters
12/2000
12/28/2000WO2000078825A1 Method for producing condensation compounds
12/28/2000WO2000078717A1 Sizing agents of enhanced performance capabilities
12/28/2000WO2000078716A1 α1B-ADRENERGIC RECEPTOR ANTAGONISTS
12/28/2000WO2000078707A1 C-2 hydroxyl protected-n-acyl(2r,3s)-3-phenylisoserine activated esters and methods for production thereof
12/28/2000WO2000078310A1 Indole compounds
12/28/2000WO2000078309A1 Indole compounds
12/28/2000DE19928236A1 Production of molecularly imprinted polymer network, useful e.g. in separation, conversion, preparation or recognition methods, by adapting conformation to template then crosslinking
12/28/2000CA2375343A1 C-2 hydroxyl protected-n-acyl(2r,3s)-3-phenylisoserine activated esters and methods for production thereof
12/28/2000CA2341542A1 .alpha.1b-adrenergic receptor antagonists
12/27/2000EP1063232A2 Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
12/27/2000EP1063231A1 Polymethine compounds, method of producing the same, and use thereof
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062217A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
12/27/2000EP1062216A1 Inhibitors of phospholipase a2
12/27/2000EP1062205A2 Inhibitors of phospholipase enzymes
12/27/2000EP1061957A1 Manganese chelates with high relaxivity in serum
12/27/2000EP1061956A1 Manganese chelates with high relaxivity in serum
12/27/2000EP0863874B1 Process for preparing dioxoazabicyclohexanes
12/27/2000CN1278257A Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same
12/27/2000CN1278248A [Indole] naphthopyrans, prepn., compositions and (co) polymer matrics contg. them, synthesis intermediates
12/27/2000CN1278244A Dipeptide nitriles
12/27/2000CN1277962A Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1277961A Novel 2,3-methylene amino acid compound, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1059904C Tricyclic compounds having fungicidal activity, their preparation and their use
12/26/2000US6166219 Treatment of diabetes and related disorders
12/26/2000US6166215 Process for producing guanidine derivatives, intermediates therefor and their production
12/26/2000US6166064 Antiinflammatory agents; antiarthritic agents
12/26/2000US6166057 Fungicides for the control of take-all disease of plants
12/26/2000US6166055 Antiinflammatory agents
12/26/2000US6166053 Antiproliferative agent for treating cancer
12/26/2000US6166050 Treatment of inflammatory and autoimmune diseases
12/26/2000US6166020 Aryl and heteroaryl alkoxynaphthalene derivatives
12/23/2000CA2312432A1 Use of melatoninergic ligands to obtain pharmaceutical compositions for the prevention or treatment of pathologies in the gastrointestinal system
12/22/2000CA2312385A1 Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
12/21/2000WO2000077032A2 Spermine:peptide-based surfactant compounds
12/21/2000WO2000077027A2 Serine protease inhibitors
12/21/2000WO2000076981A1 Piperidinyl and piperazinyl substituted benzofused lactams
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076970A2 Serine protease inhibitors
12/21/2000WO2000076969A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000WO2000076968A1 Process for the synthesis of a-nor-seco compounds with sterane skeleton
12/21/2000WO2000076967A1 Benzylpiperazinyl-indolinylethanones
12/21/2000WO2000076966A2 Indolinylamide derivatives and the use thereof as antiviral drugs
12/21/2000WO2000076521A1 Antiviral indoleoxoacetyl piperazine derivatives
12/21/2000WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000DE19927415A1 Indolinylharnstoffderivate Indolinylharnstoffderivate
12/21/2000CA2383008A1 Compounds
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2373394A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000CA2340663A1 Antiviral indoleoxoacetyl piperazine derivatives
12/20/2000EP1061074A1 Novel process and intermediates
12/20/2000EP1060166A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277195A Pentaheterocyclic benzosulfony urea compound, its preparation and herbicide with the compound as active component
12/19/2000US6162926 Fullerenes derivatized with various compounds such as by cycloaddition, attaching to the carbon skeleton with 2 single bonds selected from carbon-carbon(c-c), c-oxygen, c-nitrogen and c-sulfur; pharmaceutical formulations
12/19/2000US6162822 Bisimide compounds
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/18/2000CA2311872A1 Processes and intermediates for preparing (indole-2-carbonyl)-amides
12/14/2000WO2000075237A2 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS
12/14/2000WO2000075236A1 Extended rhodamine compounds useful as fluorescent labels
12/14/2000WO2000075140A1 7-oxo-2-azabicyclo[2.2.1]heptanes as selective muscarinic receptor antagonist
12/14/2000CA2375740A1 Ph sensitive cyanine dyes as reactive fluorescent reagents
12/14/2000CA2365075A1 Extended rhodamine compounds useful as fluorescent labels
12/13/2000EP1059291A2 Process for preparing bis(ether anhydrides)
12/13/2000EP1058553A2 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy
12/13/2000EP1058548A1 New use
12/13/2000CN1276790A Carboxamidothiazole derivs., preparation, pharmaceutical composition contg. them
12/13/2000CN1276784A Cyclic amino acids and derivs. thereof useful as pharmaceutical agents
12/13/2000CN1059433C Arylalkyl (thio) carboxamides, processes forpreparing them and pharmaceutial composition contg. them
12/12/2000US6160176 Anticoagulant agents
12/12/2000US6160128 Tritioacetylating reagents and processes for preparation thereof
12/12/2000US6160127 4-5-disubstituted-2,.beta.-nitrostyrene is subjected to a reductive cyclization in the presence of a water soluble dithionite salt
12/12/2000US6160126 Useful in preparing guanidine derivatives useful as insecticides and miticides
12/12/2000US6160123 One pot synthesis of 2-oxazolidinone derivatives
12/12/2000US6160120 Optically pure 7-chloro-2-(2-(3-(1-(7-(1h-tetrazol-5-ylmethoxy) indol-1-yl)-4-(1h-tetrazol-5-yl) butyl)phenyl)ethenyl)quinoline
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159979 Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity
12/07/2000WO2000073508A1 Methods and compositions for isolating high molecular weight dna from natural samples
12/07/2000WO2000073297A1 Substituted indolinone as tyrosine kinase inhibitors
12/07/2000WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000WO2000073264A1 Cell proliferation inhibitors
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000073258A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 458